First In Vivo Human Genome Editing to Be Tested in New Clinical Trial – The Scientist

Posted: May 20, 2017 at 6:23 am


The Scientist
First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
The Scientist
Sangamo Therapeutics will use zinc finger nucleases to introduce the gene for a missing clotting factor into the livers of men with hemophilia B.

and more »

More:
First In Vivo Human Genome Editing to Be Tested in New Clinical Trial - The Scientist

Related Posts